[vc_row][vc_column width=”1/2″][vc_single_image image=”70″ border_color=”grey” img_link_large=”” img_link_target=”_self” img_size=”701X505″ alignment=”center”][/vc_column][vc_column width=”1/2″][vc_row_inner][vc_column_inner width=”1/4″][vc_custom_heading text=”Licensing” font_container=”tag:h4|text_align:left|color:%23000000″ google_fonts=”font_family:Droid%20Sans%3Aregular%2C700|font_style:400%20regular%3A400%3Anormal”][/vc_column_inner][vc_column_inner width=”1/4″][/vc_column_inner][vc_column_inner width=”1/4″][/vc_column_inner][vc_column_inner width=”1/4″][/vc_column_inner][/vc_row_inner][vc_column_text]

While licensing deals have perhaps been born out of necessity – the patient and necessity is the mother of all invention.

Creating a partnership agreement in licensing balances, the risk and cost of early stage drugs/combinations discovery help us to bring new critical requirements which are most of the time the need of the hour. Our aim is to expand access to critical medicines for patients and for this purpose, we license products developed and manufactured by other companies and supply them to patients in markets where we have a strong marketing and sales network. This help patients get access to medicines which were not available to them otherwise.

We also create, develop and manufacture certain medicines that we may then license to other pharmaceutical companies to market and sell in particular markets. This allows our products to reach patients that otherwise would not.